X
29Jul

National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer

On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By: Manatt, Phelps & Phillips, LLP
Source Url: https://www.jdsupra.com/legalnews/national-retailer-pulls-cbd-products-45233/

Related

SBA Sets Rules For Dealing With PPP Loans In M&A Transactions

New guidance from the Small Business Administration (SBA) sheds light on questions that arise in the...

Read More >

Mind your "Ps" and "Cs" to avoid disputes (UK construction focus)

In response to COVID-19-related disruption, the Construction Leadership Council (CLC) is promoting t...

Read More >

COVID-19 Impact On Development

Not since the Great Recession of 2008 has the homebuilding industry faced a challenge like COVID-19....

Read More >

Is This Gross Misconduct That Excuses COBRA?

As many of you know, an employer does not have to offer COBRA health insurance coverage to an employ...

Read More >

It’s About Time!: DOL’s Overtime Regulations Become Final

On September 24, 2019, the U.S. Department of Labor (DOL) announced its final rule updating the earn...

Read More >

U.S. Department of Labor Rings in the New Year with New Opinion Letters Regarding FMLA and the FLSA

The U.S. Department of Labor (DOL) issued three opinion letters on January 7, 2020—one addressing t...

Read More >